Program
Lead Indication
Research
Lead OP
IND-Enabling
Phase 1
Phase 2
Phase 3
MEL-502
Radiation Dermatitis (RD)
MEL-XXX
Aesthetics
Toxicity Reduction
Radiation Protection
Anti-inflammatory
Anti-bacterial
Soothing Agent
MELANYZE
CORTICOSTEROID
ANTIBIOTICS
SILVER DRESSINGS
WHITE PETROLATUM